(C-terminal tyrosine) is highly susceptible to dephosphorylation; a mechanism that controls the extent of Syk activation and the downstream signaling in mast cells. Here, we explored the importance of the γ-chain Y 47 (N-terminal tyrosine) in mast cell signaling. We generated a highly sensitive and versatile phospho-specific antibody that recognized the phosphorylated Y 
Introduction
Mast cells express high levels of the high affinity receptor for IgE, FcεRI, which is comprised of four non-covalently associated polypeptides, the IgE-binding α-chain, the signal transduction amplifying β-chain, and the signal inducing γ-chain [1, 2] . Both the β-and γ-chain contain an immunoreceptor tyrosine-based activation motif (ITAM) that encodes the consensus sequence (D/E)XXYXXLX 7-11 -YXXL(L/I) [3] . While the γ-chain ITAM (Y 47 TGLNTRSQETY 58 ETL) is comprised of the consensus sequence (YxxL-x 7 -YxxL), the β-chain ITAM (Y 219 EELHVY 225 SPIY 229 SEL) has an additional tyrosine (Y 225 : non-canonical) residue between two canonical tyrosine (Y 219 and Y 229 ) residues [3] . Aggregation of FcεRI results in the phosphorylation of the tyrosine residues in its β-and γ-chains through association of Lyn kinase (a Src family protein tyrosine kinase) with the β chain of this receptor. Once phosphorylated these tyrosine residues serve as docking sites for recruitment of additional signaling molecules, like Syk kinase [4, 5] . Mutational analysis of some of the tyrosine residues in the β-or γ-chain ITAM revealed that they have distinct roles in mast cell signaling [6] [7] [8] [9] . For instance, previous studies have shown that Y 219 in the FcεRIβ ITAM is important for Lyn association with this receptor [6] . Our own studies [9] demonstrated that the Y 225 in this same subunit plays an important role in negatively regulating cytokine synthesis and secretion by regulating mitogen-activated protein kinases (MAPKs) and nuclear factor κB (NFκB) activation following antigen (Ag) stimulation. It has long been recognized that, once phosphorylated, the γ-chain ITAM serves as a docking site for Syk kinase and that both Y 47 and Y 58 participate in the docking and activation of Syk kinase [10, 11] . However, we recently found [12] that Y 58 (C-terminal tyrosine) serves as a regulator of Syk activation since it is rapidly dephosphorylated limiting the amount of active Syk and thus controlling the extent of mast cell effector responses. These findings demonstrate that the selective phosphorylation/dephosphorylation of ITAM tyrosine residues is not only essential for initiating signaling protein interaction and activation but also participates in controlling the rate and extent of this interaction and activation, thus regulating the extent of a mast cells' response.
For many years it was thought that the FcεRI signaling in mast cells was driven through the initial activity of Lyn kinase alone [13] . The discovery [14] of complementary signaling driven through FcεRI-dependent Fyn kinase activation led to the realization that some signals generated upon receptor engagement were relatively independent of Lyn activity. Thus, the molecular events leading to activation of phosphatidylinositol 3 OH-kinase (PI3K) and Akt (also known as protein kinase B (PKB)) were found to be more dependent on Fyn kinase than on Lyn kinase. Akt is a 56 kDa member of the serine/threonine protein kinase family that plays an important role in cell survival, proliferation, migration, and cell polarity [15] [16] [17] [18] . Akt undergoes membrane recruitment through the N-terminus PH domain that binds to phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ), a phospholipid synthesized by PI3K, leading to phosphorylation and activation of Akt. In mast cells, Akt was found to play a role in cytokine production by regulating binding of the NFκB, the nuclear factor of activated T cells (NFAT), and activator protein 1 (AP-1) to their respective binding sites in the promoter regions of IL-2 and TNFα [19] .
Given that Akt plays an essential role in mast cell effector responses and that it is activated upon FcεRI engagement in a Fyn kinase dependent manner, how the FcεRIβ and γ ITAM tyrosine's contributed in controlling Akt activation was not clear. In the current study, we set out to investigate if the FcεRIβ and γ ITAMs both contributed to Akt activation and to define which ITAM tyrosine residues were essential. For these studies we generated a novel phospho-specific monoclonal antibody to the phosphorylated γ-chain ITAM Y 47 (ITAMγ pY   47 ) as this is the dominant phosphorylated site seen upon isolation of the FcεRIγ. This antibody proved to be a highly sensitive measure of FcεRI activation in cells and tissues under various applications and led us to the discovery that Akt phosphorylation upon FcεRI engagement is almost solely dependent on the phosphorylation of Y 58 of the FcεRIγ ITAM.
Results and Discussion

Generation of a Novel Monoclonal Antibody That Specifically Recognizes the Phosphorylated FcεRIγ-Chain ITAM Y 47
To investigate the role of FcεRI phosphorylation in Akt phosphorylation we first developed a phospho-specific monoclonal antibody to the γ-chain ITAM Y We have previously shown that the phosphorylated homodimers of FcεRIγ are detected as multiple bands under non-reducing conditions with differing molecular mass [12, 20] . Western blotting of immunoprecipitated FcεRI with an antibody to phosphotyrosine identified the phosphorylated β-chain and at least four major species of phosphorylated FcεRIγ (Figure 1b , left panel) in Ag-stimulated conditions with little or no phosphorylation detected in non-stimulated conditions. Interestingly, the γ-pY 47 antibody blotting of the same stripped and reprobed blot showed a minor reactivity in resting BMMCs, demonstrating that this antibody is more sensitive in detecting phosphorylated FcεRIγthan the widely used anti-phosphotyrosine antibody 4G10 (Figure 1b , right panel). An additional six species of the phosphorylated FcεRIγ were observed following Ag stimulation. Some of the observed species were identical in both phosphotyrosine antibody and γ-pY 47 antibody blots. However, the three species (with the lowest molecular mass) seemed to be detected only by the γ-pY 47 antibody. Peptide microarray data has demonstrated that all phosphotyrosine antibody clones (i.e., 4G10, PY20, p-TYR-100) recognize their target in a sequence-specific context and that this recognition differs for each clone [21] . Our results demonstrate that this novel antibody, γ-pY
47
, recognizes its target sequence in the FcεRIγ with high selectivity and sensitivity, and recognizes more of the multiple molecular mass species (or modifications) of the FcεRIγthan the general anti-phosphotyrosine antibody 4G10.
Given the usefulness of such a reagent to assess the status of FcεRI phosphorylation directly in cell lysates, we examined whether γ-pY 
Use of the γ-pY
47
Antibody in Various Applications
The findings show that the γ-pY 47 antibody can selectively, and with high sensitivity, recognize phosphorylated FcεRIγ in whole cell lysates from various species by Western blot. However, the usefulness of such a reagent for other applications was unclear. Thus, we tested its efficacy in detecting phosphorylated FcεRIγ in immunocytochemistry, immunohistochemistry, and FACS. Double-immunostaining using the Alexa Fluor 568-labeled IgEand the γ-pY (Figure 2b ). Alexa Fluor 647 conjugated-avidin was used to visualize mast cells in skin tissues [22, 23] . As shown in Figure 2b , following PCA challenge, mast cells (a single representative cell is shown in red) was observed in the skin and the staining with γ-pY 47 antibody (green) showed punctate pattern reminiscent of FcεRI clusters. We previously published that, in systemic lupus erythematosus (SLE), activation of basophils by autoreactive IgE-containing immune complexes serves to amplify the production of autoantibodies and contributes to disease progression and severity [24] . Thus, we first examined whether γ-pY 47 antibody could detect phosphorylated FcεRI in human basophil by FACS. Human blood basophils were activated with anti-human IgE antibody for 2 min and fixed and stained with antibodies against different surface marker proteins used to identify human basophils (see Experimental Section). As shown in Figure 2c (Figure 2d ). Staining of basophils from healthy donors was very similar to isotype control staining (Figure 2d, left panel) . However, the staining with γ-pY 47 antibody in basophils from donors with active SLE was considerably higher than that of isotype control or that of the healthy donors (Figure 2d, right panel) . These findings demonstrate the utility of the γ-pY 47 antibody in determining the phosphorylation status of FcεRI during cell activation or in disease and could be a useful diagnostic tool in allergic and other diseases where IgE antibodies may play a role. The findings also raised the question of whether all signaling downstream of FcεRI engagement were similarly regulated by the ITAM tyrosine's of FcεRIβ or FcεRIγ. We previously demonstrated that Fyn kinase initiates complementary signals in mast cells [14] , which are less dependent on Lyn, Syk, or LAT1. Our findings showed that Fyn activation was important for the phosphorylation of the adapter molecule Gab2 and the activation of PI3K and the phosphorylation of Akt [14] . In cells expressing the various FcεRIβ ITAM mutants, analysis of Akt phosphorylation on T 308 (the site phosphorylated by the PI3K-dependent kinase 1) demonstrated no marked effect on its phosphorylation (Figure 3b) . However, phosphorylation of Akt was clearly dependent on expression of FcεRI because FcεRIβ −/− BMMCs (which do express FcεRI on their cell surface [9] ) failed to induce Akt T 308 phosphorylation. Thus, the data suggested that phosphorylation of Akt was likely to be dependent on the FcεRIγ, a hypothesis we subsequently explored. ) were used to detect site specific phosphorylation. Fold induction was calculated by densitometry and normalized to the respective protein or to actin.
Phosphorylation of FcεRIγ
Phosphorylation of Akt Is Largely Dependent on the Phosphorylation of FcεRIγ Y 58
Our subsequent experiments were initially aimed at addressing whether the phosphorylation of Akt was dependent on the continuous aggregation of the FcεRI. As shown in Figure 4a the use of monovalent hapten (DNP-L-Lys), which disrupts the receptor aggregation induced by a multivalent Ag (DNP 30-40 -HSA) [27, 28] , demonstrated that phosphorylation of FcεRI (as measured with γ-pY 47 antibody) is markedly abrogated by such treatment, however, phosphorylation can be restored when a general inhibitor of tyrosine phosphatases (pervanadate) is added to the cells. This suggested that disaggregation of FcεRI by hapten (30 s after Ag addition) makes the receptor susceptible to dephosphorylation by tyrosine phosphatases. Given this finding, we asked if the phosphorylation of downstream molecules (whether tyrosine or serine/threonine phosphorylated) was similarly affected by disaggregation of FcεRI. As shown in Figure 4b . We first verified that mutation at either of these sites had an impact on Syk and LAT1 phosphorylation as previously described [12] . As shown in Figure 4c is key in initiating FcεRI-dependent Akt phosphorylation (see Model, Figure 5 ) and this occurs upstream of the key signals (like Fyn kinase) that are essential for the activation of Akt [14] . This is also consistent with the finding that the absence of Lyn, which causes an increase in Fyn kinase activity [29] , results in defective FcεRI phosphorylation but enhanced Akt phosphorylation. In contrast, Fyn-deficiency does not affect FcεRI phosphorylation but causes a marked dampening of Akt phosphorylation [14] . is an upstream regulator of the Fyn-Gab2-Akt pathway.
Experimental Section
Generation of Phospho-Specific Antibody to the Phosphorylated FcRγ Y
(γ-pY
)
Antigen peptide (DAVpYTGLNTRSQETC) was conjugated with KLH as immunogen and mice were immunized with the conjugated peptide. Hybridoma generation was performed by GenScript (Piscataway, NJ, USA). Enzyme-linked immunosorbent assays (ELISAs) were used for primary screening of the resulting hybridomas using culture supernatants. Non-phosphorylated peptide (DAVYTGLNTRSQETC) was used as a negative control.
Animals
Mice used in this study were wild-type (WT), B6-Ms4a2 
Human Blood Samples
Samples were collected from adult subjects enrolled in a long-term natural history study of SLE. The study was approved by the Institutional Review Board of National Institute of Arthritis and Musculoskeletal and Skin Diseases. All subjects fulfilled the American College of Rheumatology classification criteria for SLE. Control samples were obtained from healthy blood donors. All subjects provided written informed consent.
General Reagents
Mouse anti-2,4-dinitrophenol (DNP) monoclonal IgE antibody was purified from culture supernatants of the H1-DNP-ε-26.82 hybridoma [30] . DNP [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] -HSA, DNP-L-Lysine, sodium orthovanadate (Na 3 VO 4 ), and Hydrogen peroxide were purchased from Sigma-Aldrich (St. Louis, MO, USA). Mouse monoclonal antibody to FcεRI ITAMβ (clone: JRK) was previously described [31] . Rabbit polyclonal antibody to Lyn and actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-phospho-Syk (Y 519/520 ), anti-phospho-Akt (T 308 ), and anti-phospho-LAT1 (Y 191 ) antibodies were purchased from Cell Signaling Technology (Boston, MA, USA). Anti-mouse IgE antibody was purchased from SouthernBiotec (Birmingham, AL, USA). Anti-phosphotyrosine 4G10 mAb was from Upstate Biotechnology (Lake Placid, NY, USA). APC-conjugated anti-human CD123, Pacific Blue-conjugated anti-human FcεRIα, and PercPCy5.5 conjugated anti-human CD203c were purchased from Biolegend (San Diego, CA, USA). PE-conjugated anti-human CD303 was purchased from MiltenyiBiotec (Auburn, CA, USA).
Cell Cultures
Total bone marrow from the femurs of wild-type (WT); FcRβ Cultures were checked periodically for the extent of mast cell differentiation (CD117 + ) and purity by FcεRI expression. Cells were used when cultures achieved ≥95% of the population expressing both markers.
Viral Transduction of BMMCs with Mutant FcεRIGenes
For expression of FcRIβ mutants, lentivirus gene transduction was used as previously described [20, 32] . Viral supernatants were produced by transfecting the packaging cell 293LTV with β-chain mutants in the pLenti6 vector using Lipofectamine 2000 (Invitrogen). Some cells were also mock-transfected with LacZ/pLenti6 vector as a negative control. For expression of FcRImutants, viral supernatants were produced by transfecting the retroviral packaging cells Phoenix-E with wild type or mutated FcRγ in the pMX-puro vector as previously described [12, 20] . Empty pMX-puro vector was used as a negative control. After infection, cells were washed and allowed to grow in IL-3-and SCF-containing medium for 2 days before initiating the selection of transduced cells with 8 μg/mL of blasticidin S (Invitrogen) and 3 μg/mL of puromycin (Invitrogen) for lentiviral-or retroviraltransduced cells, respectively. Following 2 weeks of selection, cells were analyzed for FcεRI expression and used when >95% of the cells expressed this receptor.
Ag stimulation, Immunoprecipitation, and Western Blotting
For Ag-dependent stimulation of BMMCs, cells were sensitized with 1 μg/mL IgE in RPMI 1640 without cytokines at 37 °C for 3 h. Cells were then washed and stimulated at 37 °C with 30 ng/mL Ag (DNP-HSA) or with the indicated concentration in Tyrode's buffer (135 mM NaCl, 5 mM KCl, 20 mM HEPES, 5.6 mM glucose, 1 mM MgCl 2, 1.8 mM CaCl 2 , 0.05% BSA (pH 7.4)). In some experiments, cells were stimulated with pervanadate (prepared freshly by incubating 100 mM vanadate with 100 mM H 2 O 2 ) for 15 min at room temperature, as indicated. For kinetic experiments, Ag-stimulation time varied as indicated. Cell lysates were prepared by incubation of 20 × 10 6 cells in 1 mL BBS buffer containing 1.0% NP-40 and 60 mMoctyl β-d-glucopyranoside (Sigma-Aldrich, St. Louis, MO, USA) on ice for 15 min. Lysates were clarified by centrifugation for 15 min at 14,000 × g at 4 °C and supernatants collected. For Western blotting, the membranes were blocked for 1 h at room temperature with Odyssey blocking buffer (Li-COR Biosciences, Lincoln, NE, USA) diluted two times in PBS. Membranes were then incubated with the indicated primary Abs, followed by secondary Abs linked to infrared fluorescent dyes. After washings with PBS-0.1% Tween-20 (Sigma-Aldrich), the immuno-reactive proteins were visualized with IRDye800-conjugated goat anti-mouse IgG (Rockland Immunochemicals, Boyertown, PA, USA) or Alexa Fluor 680-conjugated goat anti-rabbit IgG (Invitrogen) and detected by an Odyssey infrared imaging system (Li-Cor Biosciences). For whole-mount immunostaining, the ears of WT mice were sensitized with anti-DNP IgE (75 ng) in the contralateral ear. The next day, mice were retroorbitally challenged with Ag. After 5 min, the mice were euthanized, and the ears were collected. The collected ears were fixed in 1% paraformaldehyde overnight at 4 °C. The tissues were blocked and permeabilized in PBS containing 1% bovine serum albumin and 0.1% Triton X-100 for 1 h, and then incubated withAlexa Fluor 488 conjugated -pY 47 antibody overnight at 4 °C. Tissues were washed and incubated with Alexa Fluor 647 conjugated avidin for 1 h at 4 °C. After washing with PBS, tissue samples were embedded on a slide using Fluoromount G (SouthernBiotec). The fluorescence of Alexa Fluor 488 and Alexa Fluor 647 was detected through a band pass filter (505-530 nm) and a long pass filter (>650 nm), respectively.
Confocal Microscopy
Flow Cytometry
Blood samples from healthy donors or active SLE patients were harvested in heparin-coated tubes. Samples (1 mL) were stimulated for 2 min at 37 °C with anti-human IgE antibody (1:100 dilution: Beckman Coulter). The cells were immediately fixed with 20 × volumes of pre-warmed BD TM Phosphoflow Lyse/Fix Buffer (BD biosciences) and incubated for 10 min at 37 °C and pelleted by centrifugation (500 × g, 10 min). Cells were then washed in PBS and resuspended in 1 mL of FACS buffer (PBS supplemented with 1.0% BSA, 0.05% NaN 3 ). Cells were subsequently processed for extracellular staining with the surface markers: APC-conjugated anti-human CD123, PE-conjugated anti-human CD303, Pacific Blue-conjugated anti-human FcεRIα, and PercPCy5. 
Conclusions
The findings herein demonstrate the sensitivity and selectivity of a novel phospho-specific antibody to FcεRI Y 47 , which showed considerable versatility in various applications. Using this antibody, we found that the FcεRIβ Y 
